Sharp dip in sales volumes of imported packaged medicines to Russia

According to the analytical study carried out by RNC Pharma, deliveries of imported finished pharmaceutical products to Russia in the period from January to April 2018 were up 0.9% in Russian rouble terms, and down 7.9% in terms of packages.

Elena Vatutina, an expert on the Russian pharmaceutical market and chief executive of Pharmznanie, a provider of marketing services to foreign companies in the Russian market, commented on the RNC’s data: “The first months of 2018 have shown reduced import volumes of certain pharmaceutical products to Russia. To me this reduction is due to a national trend of saving on expensive original medicines and buying generics. However, there are a number of products that are on an upward trend, for example, homeopathic medicine. The use of dietary supplements is also increasing, which is facilitated by the penetration of foreign manufacturers into market segments in remote regions of Russia.”

In Russian roubles, January–April 2018